Maze Therapeutics, Inc.(MAZE)
$36.73+1.28 (+3.61%)
MAZE
Maze Therapeutics, Inc. financials statements
$36.73
At close:+1.28 (+3.61%)
Want to see MAZE full AI Analyst Report?
Maze Therapeutics, Inc. (MAZE) Ratios
128 Followers
Maze Therapeutics, Inc. Ratios
MAZE's free cash flow for Q3 2026 was $-33.13M. For the 2026 fiscal year, MAZE's free cash flow was decreased by $-288.00K and operating cash flow was $-32.84M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Mar 25 | Dec 23 | Dec 22 |
|---|---|---|---|---|
| Liquidity Ratios | ||||
| Current Ratio | 15.50 | 9.76 | 2.09 | 5.11 |
| Quick Ratio | 15.50 | 9.76 | 2.09 | 5.11 |
| Cash Ratio | 8.39 | 9.52 | 1.79 | 4.81 |
| Solvency Ratio | -3.05 | 1.27 | -1.57 | -2.29 |
| Operating Cash Flow Ratio | -4.96 | 3.67 | -5.32 | -4.77 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 307.56M | $ 158.03M | $ -27.34M | $ 57.63M |
| Leverage Ratios | ||||
| Debt-to-Assets Ratio | 0.06 | 0.11 | 0.69 | 0.21 |
| Debt-to-Equity Ratio | 0.07 | 0.14 | 4.94 | 0.32 |
| Debt-to-Capital Ratio | 0.06 | 0.12 | 0.83 | 0.24 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.67 | 0.00 |
| Financial Leverage Ratio | 1.12 | 1.22 | 7.11 | 1.48 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.03 | 0.00 |
| Interest Debt Per Share | 0.54 | 0.61 | 1.13 | 0.73 |
| Net Debt to EBITDA | 1.29 | -3.00 | -0.22 | 0.63 |
| Profitability Margins | ||||
| Gross Profit Margin | 0.00% | 100.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 31.88% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 33.85% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 34.38% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 31.88% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 31.18% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 31.18% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 97.81% | 100.00% | 100.00% |
| EBT Per EBIT | 91.76% | 92.74% | 101.89% | 103.53% |
| Return on Assets (ROA) | -33.02% | 21.71% | -140.43% | -76.65% |
| Return on Equity (ROE) | -36.94% | 26.53% | -998.76% | -113.31% |
| Return on Capital Employed (ROCE) | -38.15% | 26.19% | -178.57% | -85.95% |
| Return on Invested Capital (ROIC) | -37.67% | 25.09% | -165.14% | -83.17% |
| Return on Tangible Assets | -33.02% | 21.71% | -140.43% | -76.65% |
| Earnings Yield | -7.36% | 7.48% | -14.38% | -16.46% |
| Efficiency Ratios | ||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 1.34 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 5.60 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.70 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 1.69 | 0.00 | 0.00 |
| Cash Conversion Cycle | -272.50 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 272.50 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | ||||
| Operating Cash Flow Per Share | -2.60 | 1.73 | -1.98 | -2.27 |
| Free Cash Flow Per Share | -2.62 | 1.71 | -1.99 | -2.31 |
| Dividend Paid and CapEx Coverage Ratio | -140.98 | 66.22 | -196.89 | -50.46 |
| Capital Expenditure Coverage Ratio | -140.98 | 66.22 | -196.89 | -50.46 |
| Operating Cash Flow Coverage Ratio | -4.80 | 2.85 | -1.75 | -3.09 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.45 | 0.00 | 0.00 |
| Free Cash Flow Yield | -6.33% | 10.71% | -12.50% | -14.49% |
| Valuation Ratios | ||||
| Price-to-Earnings (P/E) Ratio | -13.58 | 205.01 | -6.95 | -6.07 |
| Price-to-Sales (P/S) Ratio | 0.00 | 4.17 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 5.02 | 3.55 | 69.45 | 6.88 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -15.79 | 9.34 | -8.00 | -6.90 |
| Price-to-Operating Cash Flow Ratio | -15.91 | 9.20 | -8.04 | -7.04 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -1.98 | 0.55 | 0.00 |
| Enterprise Value Multiple | -12.54 | 9.32 | -7.61 | -5.88 |
| Enterprise Value | 1.61B | 528.36M | 718.71M | 630.38M |
| EV to EBITDA | -12.54 | 9.32 | -7.61 | -5.88 |
| EV to Sales | 0.00 | 3.15 | 0.00 | 0.00 |
| EV to Free Cash Flow | -14.32 | 7.06 | -8.24 | -6.23 |
| EV to Operating Cash Flow | -14.42 | 6.96 | -8.28 | -6.35 |
| Tangible Book Value Per Share | 8.26 | 4.50 | 0.23 | 2.32 |
| Shareholders’ Equity Per Share | 8.26 | 4.50 | 0.23 | 2.32 |
| Tax and Other Ratios | ||||
| Effective Tax Rate | 0.00 | 0.02 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 3.82 | 0.00 | 0.00 |
| Net Income Per Share | -3.05 | 1.19 | -2.29 | -2.63 |
| Tax Burden | 1.00 | 0.98 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.02 | 1.04 |
| Research & Development to Revenue | 0.00 | 0.50 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.16 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.06 | 0.00 | 0.00 |
| Income Quality | 0.85 | 1.45 | 0.86 | 0.86 |
Currency in USD
